Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 13, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 21
- 0 vs. Q2 2025
- Portfolio value
- $437.5M
- −$138.7M (−24.1%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SENSSenseonics Holdings, Inc. | COM | 43,426 | $18.9K | <0.1% | 00.0% | Unchanged | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $42.7K | <0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM NEW | 31,305 | $166.5K | <0.1% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 1,675,000 | $319.9K | 0.1% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 277,777 | $550.0K | 0.1% | 00.0% | Unchanged | History |
| ANTXAN2 Therapeutics, Inc. | COM | 715,295 | $908.4K | 0.2% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM NEW | 157,646 | $923.8K | 0.2% | +144,509+1,100.0% | AddedConverted for a 1-for-12 split | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $1.44M | 0.3% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $4.44M | 1.0% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $4.97M | 1.1% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $7.59M | 1.7% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $10.9M | 2.5% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,970,022 | $12.9M | 2.9% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $13.7M | 3.1% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $15.6M | 3.6% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 349,406 | $17.3M | 3.9% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $27.3M | 6.2% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $29.5M | 6.7% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 1,272,214 | $60.8M | 13.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 5,376,344 | $64.5M | 14.7% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 1,658,361 | $163.5M | 37.4% | −2,000,000−54.7% | Reduced | History |